Abstract
Mesenchymal stem cell (MSC) therapy represents a promising approach for the treatment of osteoarthritis (OA). MSCs can be readily isolated from multiple sources and expanded ex vivo for possible clinical application. They possess a unique immunological profile and regulatory machinery that underline their therapeutic effects. They also have the capacity to sense the changes within the tissue environment to display the adequate response. Indeed, there is a close interaction between MSCs and the host cells. Accordingly, MSCs demonstrate encouraging results for a variety of diseases including OA. However, their effectiveness needs to be improved. In this review, we selected to discuss the importance of the immunological features of MSCs, including the type of transplantation and the immune and blood compatibility. It is important to consider MSC immune evasive rather than immune privileged. We also highlighted some of the actions/mechanisms that are displayed during tissue healing including the response of MSCs to injury signals, their interaction with the immune system, and the impact of their lifespan. Finally, we briefly summarized the results of clinical studies reporting on the application of MSCs for the treatment of OA. The research field of MSCs is inspiring and innovative but requires more knowledge about the immunobiological properties of these cells. A better understanding of these features will be key for developing a safe and efficient medicinal product for clinical use in OA.
Highlights
Recent advances in stem cell research have highlighted the role played by these cells and their environment in tissue homeostasis
We described the characteristics of the transplantation, the immune and blood compatibility, which are relevant for the therapy outcome
We have previously shown that Mesenchymal stem cell (MSC) express several relevant receptors, such as the receptor for advanced glycation endproducts (RAGE), C-type lectin receptors (CLRs, including DECTIN-1, DECTIN-2 and MINCLE), leukotriene B4 (LTB4) receptors (BLT1 and BLT2) and cysteinyl leukotriene (CysLTs) receptors (CYSLTR1 and CYSLTR2) (Najar et al, 2018)
Summary
Recent advances in stem cell research have highlighted the role played by these cells and their environment in tissue homeostasis. The therapeutic effects of MSCs were thought to be mediated based on their multilineage differentiation ability that enabled them to replace damaged cells in injured tissue. MSCs modulate the local tissue homeostasis and immune responses (Nolta et al, 2020).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.